Please try another search
Krebs Biochemicals & Industries Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 105.81 million compared to INR 106.41 million a year ago. Revenue was INR 106.19 million compared to INR 107.7 million a year ago. Net loss was INR 53.33 million compared to INR 81.37 million a year ago. Basic loss per share from continuing operations was INR 2.47 compared to INR 3.77 a year ago. Diluted loss per share from continuing operations was INR 2.47 compared to INR 3.77 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 129.77 | 148.9 | 105.81 | 114.61 |
Gross Profit | 117 | 128.36 | 102.16 | 62.73 |
Operating Income | -37.91 | -24.37 | -42.36 | -60.38 |
Net Income | -49.77 | -35.71 | -53.33 | -69.4 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 1781.28 | 1749.82 | ||
Total Liabilities | 2864.94 | 2744.44 | ||
Total Equity | -1083.66 | -1083.66 | -994.62 | -994.62 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review